These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18049831)

  • 21. Acute effects of statin on reduction of angiopoietin-like 2 and glyceraldehyde-derived advanced glycation end-products levels in patients with acute myocardial infarction: a message from SAMIT (Statin for Acute Myocardial Infarction Trial).
    Shimomura M; Oyama J; Takeuchi M; Shibata Y; Yamamoto Y; Kawasaki T; Komoda H; Kodama K; Sakuma M; Toyoda S; Inoue Y; Mine D; Natsuaki M; Komatsu A; Hikichi Y; Yamagishi S; Inoue T; Node K
    Heart Vessels; 2016 Oct; 31(10):1583-9. PubMed ID: 26699899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of long-term statin pretreatment on myocardial damage in ST elevation myocardial infarction (from the AIDA STEMI CMR Substudy).
    Fuernau G; Eitel I; Wöhrle J; Kerber S; Lauer B; Pauschinger M; Schwab J; Birkemeyer R; Pfeiffer S; Mende M; Brosteanu O; Neuhaus P; Desch S; de Waha S; Gutberlet M; Schuler G; Thiele H
    Am J Cardiol; 2014 Aug; 114(4):503-9. PubMed ID: 24994545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Present treatment of acute myocardial infarction in patients over 75 years--data from the Berlin Myocardial Infarction Registry (BHIR).
    Schuler J; Maier B; Behrens S; Thimme W
    Clin Res Cardiol; 2006 Jul; 95(7):360-7. PubMed ID: 16741630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality.
    Fonarow GC; Wright RS; Spencer FA; Fredrick PD; Dong W; Every N; French WJ;
    Am J Cardiol; 2005 Sep; 96(5):611-6. PubMed ID: 16125480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of pretreatment with statins on infarct size in patients with acute myocardial infarction who receive fibrinolytic therapy.
    Kiyokuni M; Kosuge M; Ebina T; Hibi K; Tsukahara K; Okuda J; Iwahashi N; Maejima N; Kusama I; Komura N; Nakayama N; Umemura S; Kimura K
    Circ J; 2009 Feb; 73(2):330-5. PubMed ID: 19096192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome.
    Claeys MJ; Bosmans J; Veenstra L; Jorens P; De RaedtH ; Vrints CJ
    Circulation; 1999 Apr; 99(15):1972-7. PubMed ID: 10209000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of reperfusion arrhythmia on myocardial apoptosis and left ventricular remodeling in patients with acute myocardial infarction].
    Wang SY; Chen J; Yang XC; Chi HJ; Liu XL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jan; 35(1):59-62. PubMed ID: 17386168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preprocedural statin therapy reduces the risk and extent of cardiac biomarker release following percutaneous coronary intervention.
    Veselka J; Procházková S; Duchonová R; Homolová I; Tesar D; Bybee KA
    Heart Vessels; 2006 May; 21(3):146-51. PubMed ID: 16715188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of chronic statin treatment on vascular remodeling determined by intravascular ultrasound in patients with acute myocardial infarction.
    Jinnouchi H; Sakakura K; Wada H; Ishida K; Arao K; Kubo N; Sugawara Y; Funayama H; Ako J; Momomura S
    Am J Cardiol; 2014 Mar; 113(6):924-9. PubMed ID: 24456817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting survival with reperfusion arrhythmias during primary percutaneous coronary intervention for acute myocardial infarction.
    Ilia R; Zahger D; Cafri C; Abu-Ful A; Weinstein JM; Yaroslavtsev S; Gilutz H; Amit G
    Isr Med Assoc J; 2007 Jan; 9(1):21-3. PubMed ID: 17274350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction.
    Iwakura K; Ito H; Kawano S; Shintani Y; Yamamoto K; Kato A; Ikushima M; Tanaka K; Kitakaze M; Hori M; Higashino Y; Fujii K
    J Am Coll Cardiol; 2001 Aug; 38(2):472-7. PubMed ID: 11499740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of statin therapy on ventricular late potentials in acute myocardial infarction.
    Kayikcioglu M; Can L; Evrengul H; Payzin S; Kultursay H
    Int J Cardiol; 2003 Jul; 90(1):63-72. PubMed ID: 12821221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implications of ventricular arrhythmia "bursts" with normal epicardial flow, myocardial blush, and ST-segment recovery in anterior ST-elevation myocardial infarction reperfusion: a biosignature of direct myocellular injury "downstream of downstream".
    Majidi M; Kosinski AS; Al-Khatib SM; Smolders L; Cristea E; Lansky AJ; Stone GW; Mehran R; Gibbons RJ; Crijns HJ; Wellens HJ; Gorgels AP; Krucoff MW
    Eur Heart J Acute Cardiovasc Care; 2015 Feb; 4(1):51-9. PubMed ID: 25063574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Termination of reperfusion arrhythmia by coronary artery occlusion.
    Grech ED; Ramsdale DR
    Br Heart J; 1994 Jul; 72(1):94-5. PubMed ID: 8068480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statins reduce peri-procedural complications in carotid stenting.
    Reiff T; Amiri H; Rohde S; Hacke W; Ringleb PA
    Eur J Vasc Endovasc Surg; 2014 Dec; 48(6):626-32. PubMed ID: 25240903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Attenuation of reperfusion phenomenon by reperfusion using leukocyte-depleted blood during direct percutaneous transluminal coronary angioplasty for acute myocardial infarction].
    Watanabe S; Iseki H; Tanaka K; Ishibashi H; Tanaka K; Takei Y; Ejiri N
    J Cardiol; 1999 Mar; 33(3):145-52. PubMed ID: 10225194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of acute administration of statins on coronary microcirculation during the pre-revascularization period in patients with myocardial infraction.
    Paraskevaidis IA; Iliodromitis EK; Ikonomidis I; Rallidis L; Hamodraka E; Parissis J; Andoniadis A; Tzortzis S; Anastasiou-Nana M
    Atherosclerosis; 2012 Jul; 223(1):184-9. PubMed ID: 22648087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic pretreatment of metformin is associated with the reduction of the no-reflow phenomenon in patients with diabetes mellitus after primary angioplasty for acute myocardial infarction.
    Zhao JL; Fan CM; Yang YJ; You SJ; Gao X; Zhou Q; Pei WD
    Cardiovasc Ther; 2013 Feb; 31(1):60-4. PubMed ID: 21884027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased prevalence of late potentials with mechanical versus thrombolysis-induced reperfusion in acute myocardial infarction.
    Karam C; Golmard J; Steg PG
    J Am Coll Cardiol; 1996 May; 27(6):1343-8. PubMed ID: 8626942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-hospital and one-year outcomes of patients with high-risk acute myocardial infarction treated with thrombolysis or primary coronary angioplasty.
    Steffenino G; Santoro GM; Maras P; Mauri F; Ardissino D; Violini R; Chiarella F; Lucci D; Marini M; Baldasseroni S; Maggioni AP;
    Ital Heart J; 2004 Feb; 5(2):136-45. PubMed ID: 15086144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.